PGEE in pharmaceutical plants: role and paperwork

Technical article · Eapearl Chemical · 16 September 2026

In a pharmaceutical plant a solvent is judged twice: once on whether it does the job, and once on whether you can prove what happened to it afterwards. Propylene glycol ethyl ether tends to pass the first test easily and the second only if it was bought with that second test in mind, which is where most of the avoidable trouble starts.

Where the ethyl homologue actually gets used

Propylene glycol ethyl ether — 1-ethoxy-2-propanol, C₅H₁₂O₂, CAS 1569-02-4, molar mass 104.15 — is a coupling solvent: an ether oxygen at one end, a free hydroxyl at the other, miscible with water and with most organic phases at the same time. In regulated manufacturing that dual affinity puts it in a small number of recognisable places.

• Equipment and line cleaning. Residues that are neither cleanly water-soluble nor cleanly hydrocarbon-soluble — polymer films, coating overspray, adhesive and label residues, ink from coding equipment — respond to a solvent that bridges both. The slower evaporation of the ethyl homologue compared with its methyl relative matters here: the solvent has to stay wet on a vertical surface long enough to work.
• Coating and film-forming operations. Where an aqueous coating system needs a coalescing or flow aid, a glycol ether that stays in the film through the drying window and then leaves is doing exactly the job a coalescent is asked to do.
• Analytical and laboratory duties. Sample preparation and extraction where a single-phase system spanning polar and non-polar components is convenient.
• Non-sterile topical and external preparations. A minority use and a jurisdiction-specific one, which must be established against the applicable regulatory framework for that dosage form and market rather than assumed from industrial practice.

Two of those four are cleaning, and that is representative. The largest pharmaceutical consumption of this class of solvent is not in product; it is in making equipment fit to run the next batch.

The isomer question, asked first

The propylene-series glycol ethers exist as two structural isomers. The commercial material is dominated by the isomer carrying a secondary hydroxyl group; the minor isomer is a primary alcohol and therefore open to an oxidative metabolic route the major isomer does not take. That structural difference is the foundation of the toxicological case for the propylene series over the ethylene series, and it is a grade property, not a fact about the series name.

Commercial specifications cap the minor isomer at a low level, typically a fraction of a percent. For industrial use, the cap is a background fact. For pharmaceutical use, three things follow:

• The cap must appear as a reported specification parameter with a stated analytical method, not as a general claim in a technical brochure.
• The method must be capable of resolving the two isomers. A purity figure from a method that co-elutes them is not evidence about the ratio.
• Any supplier process change that could shift the ratio is a change you need notified, which brings it inside the change-control commitment discussed below.

Residual solvent: the question the dossier will ask

Every processing solvent in a regulated plant eventually faces the same question: how much of it can remain in the product, and how do you know it does not exceed that? The international guideline on residual solvents classifies a defined set of substances by toxicological concern and assigns limits accordingly. A solvent that does not appear in those class tables is not thereby exempt and is certainly not automatically in the lowest-concern class. Where no classification exists, the manufacturer derives and justifies a limit from the available toxicological data and the maximum daily dose of the medicinal product, and that justification becomes a reviewable dossier element.

The practical consequence is that the specific CAS number has to be checked against the current version of the guideline at the time the work is done, rather than inferred from a related glycol ether that happens to be listed. Two homologues differing by a methylene group can occupy different regulatory positions, and an assumption made once at development tends to survive unchallenged into commercial supply.

Analytically, this class is a straightforward headspace gas chromatography problem, but the method must be validated for the actual matrix and must separate the solvent from anything the process could produce from it. Method development is cheap at the development stage and expensive during an inspection.

Cleaning validation, where the solvent is both tool and residue

When the solvent is used to clean, it becomes a residue in its own right. The chain is the familiar one and every link is a document: establish a health-based limit from toxicological data; convert it to a surface or rinse limit for the equipment train; develop a recovery-verified sampling method, whether swab or rinse; demonstrate the cleaning procedure meets it repeatedly.

Two errors recur. The first is drawing the limit from the safety data sheet, which is a hazard communication document about worker exposure and emergency response, not a toxicological dossier about patient exposure. The second is validating with the solvent grade that was on site during development and then buying a different grade on price. If the impurity profile changes, the residue you validated for is not the residue you now have.

What a pharmaceutical buyer has to pin down

Hazard regime on the floor

Handling controls follow the classification the supplier declares, and the label to read is the one on the drum. The working profile for this solvent in trade combines flammability with narcotic vapour effects, which puts ignition control, bonding and earthing during transfer, and breathing-zone extraction at the front of the risk assessment. Verify in the safety data sheet whether the statements derive from a harmonised entry or from the supplier’s own classification, because a harmonised entry is a legal minimum while a self-classification is the supplier’s assessment and can differ between sources for the same substance.

One practical note that belongs to regulated plants specifically: solvent used for cleaning in a classified area is subject to the same filtration, container and dispensing controls as everything else brought into that area, and the bulk grade that suits the workshop is usually not the presentation that suits a cleanroom. That is a packaging and documentation difference, not a chemistry one, and it is easier to specify at the outset than to retrofit.

If you are qualifying this solvent for a regulated process and want the specification parameters and documentation set reviewed against your intended use, tell us where in the process it sits and we will work from there rather than from a grade name.